Not trying to pick a fight, but if you are asking those type questions you know nothing about Neurocrine. Do you know they have been around 18 years and have yet to produce a commercial product? Do you know all their revenue comes from partnership deals for future drug development? Have you ever heard of Indiplon and the Pfizer partnership terminated in 2006/2007? Price earnings ratio means nothing for a company like Neurocrine, it is all about the efficacy and safety of drugs in the pipeline. Have a good day.
NBIX is a 4 year nightmare, I'm ready to cut my loss and move on!!!
Indiplon was the drug touted by NBIX as the savior for insomnia. Unfortunately, I fell under the spell that NBIX was going to get Indiplon or another sexy alluring blockbuster drug approved for market; all we got was tittilation with major milestones payments and promises for the next big drug blockbuster.
Sadly, it's just been a neverending story,after stories. I've finally waken from this nightmare and realize NBIX's extensive pipeline is only pipe dreams evolving to nightmare for shareholders.
I just felt the need to write it down, express my displeasure with NBIX management and their lousy performance for which they are richly awarded $1mill bonuses and compensation.
Mgmt gets the Goldmine, Investors get the Shaft!
Four years later, for my loyalty and patience, I get rewards of a 40% loss! Perhaps, as another poster pointed out, NBIX is only for Range Trading; NBIX is definitely not for a Buy 'n Hold investment.
There, I vented and feel better. Hope all you Longs better luck than I've had with NBIX.